Pierre d'EPENOUX

Chief Executive Officer

Pierre d'EPENOUX

Pierre d’Epenoux, Chief Executive Officer, brings to Imcheck Therapeutics over 20 years of international experience in strategic planning, corporate development and operational management with global pharmaceutical companies & biotech.

In 1995, Pierre founded & managed an Asian affiliate of Merck/Lipha in Vietnam-Laos-Cambodia. Four years later, he joined Merck KGaA in Darmstadt as director of Mergers & Acquisitions. In 2002, he joined Baxter Healthcare as Senior Director of Business Development where he led most of the global restructuring of the renal business.

In 2009, Pierre was appointed Head of Strategy & Business Development Europe at Sanofi, a position he held for four years before joining Theravectys, an emerging Paris-based biotech player developing lentiviral-vector based therapies as its Chief Strategy Officer.